Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis

• April S. Chan ,

  Contributed equally to this work with: April S. Chan, Kristian K. Jensen, Dimitris Skokos

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America

  ⨯
• Kristian K. Jensen ,

  Contributed equally to this work with: April S. Chan, Kristian K. Jensen, Dimitris Skokos

  Current address: Department of Cardiovascular Diseases, Merck Research Laboratories, Rahway, New Jersey, United States of America

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America

  ⨯
• Dimitris Skokos ,

  Contributed equally to this work with: April S. Chan, Kristian K. Jensen, Dimitris Skokos

  Current address: Regeneron Pharmaceuticals, Tarrytown, New York, United States of America

  Affiliation Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, United States of America

  ⨯
• Stephen Doty,

  Affiliation Hospital for Special Surgery, New York, New York, United States of America

  ⨯
• Hannah K. Lederman,

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America

  ⨯
• Rosandra N. Kaplan,

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Shahin Rafii,

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Genetic Medicine, Weill Cornell Medical College, New York, New York, United States of America

  ⨯
• Stefano Rivella ,

  * E-mail: str2010@med.cornell.edu (SR); dcl2001@med.cornell.edu (DL)

  Affiliation Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America

  ⨯
• David Lyden

  * E-mail: str2010@med.cornell.edu (SR); dcl2001@med.cornell.edu (DL)

  Affiliations Department of Pediatrics and Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, United States of America, Department of Pediatric Hematology-Oncology, Children's Cancer and Blood Foundation Laboratories, Weill Medical College of Cornell University, New York, New York, United States of America, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯